349 related articles for article (PubMed ID: 9566619)
1. The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems.
Lawrence AD; Sahakian BJ
Neurochem Res; 1998 May; 23(5):787-94. PubMed ID: 9566619
[TBL] [Abstract][Full Text] [Related]
2. The cholinergic system in the pathophysiology and treatment of Alzheimer's disease.
Hampel H; Mesulam MM; Cuello AC; Farlow MR; Giacobini E; Grossberg GT; Khachaturian AS; Vergallo A; Cavedo E; Snyder PJ; Khachaturian ZS
Brain; 2018 Jul; 141(7):1917-1933. PubMed ID: 29850777
[TBL] [Abstract][Full Text] [Related]
3. Reappraising neurotransmitter-based strategies.
Möller HJ
Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S53-9. PubMed ID: 10332935
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer disease, attention, and the cholinergic system.
Lawrence AD; Sahakian BJ
Alzheimer Dis Assoc Disord; 1995; 9 Suppl 2():43-9. PubMed ID: 8534423
[TBL] [Abstract][Full Text] [Related]
5. Beyond the cholinergic hypothesis: do current drugs work in Alzheimer's disease?
Martorana A; Esposito Z; Koch G
CNS Neurosci Ther; 2010 Aug; 16(4):235-45. PubMed ID: 20560995
[TBL] [Abstract][Full Text] [Related]
6. The history of the cholinergic hypothesis.
Contestabile A
Behav Brain Res; 2011 Aug; 221(2):334-40. PubMed ID: 20060018
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: a disorder of cortical cholinergic innervation.
Coyle JT; Price DL; DeLong MR
Science; 1983 Mar; 219(4589):1184-90. PubMed ID: 6338589
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Alzheimer's disease: an evaluation of the cholinergic approach.
Lemière J; Van Gool D; Dom R
Acta Neurol Belg; 1999 Jun; 99(2):96-106. PubMed ID: 10427352
[TBL] [Abstract][Full Text] [Related]
9. Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease.
Robbins TW; McAlonan G; Muir JL; Everitt BJ
Behav Brain Res; 1997 Feb; 83(1-2):15-23. PubMed ID: 9062655
[TBL] [Abstract][Full Text] [Related]
10. Effect of cholinesterase inhibitors on attention.
Pepeu G; Giovannini MG; Bracco L
Chem Biol Interact; 2013 Mar; 203(1):361-4. PubMed ID: 23047023
[TBL] [Abstract][Full Text] [Related]
11. Cholinergic strategies in the treatment of Alzheimer's disease.
Davidson M; Stern RG; Bierer LM; Horvath TB; Zemishlani Z; Markofsky R; Mohs RC
Acta Psychiatr Scand Suppl; 1991; 366():47-51. PubMed ID: 1897375
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies.
Auld DS; Kornecook TJ; Bastianetto S; Quirion R
Prog Neurobiol; 2002 Oct; 68(3):209-45. PubMed ID: 12450488
[TBL] [Abstract][Full Text] [Related]
13. Beyond Acetylcholinesterase Inhibitors: Novel Cholinergic Treatments for Alzheimer's Disease.
Kamkwalala AR; Newhouse PA
Curr Alzheimer Res; 2017; 14(4):377-392. PubMed ID: 27697062
[TBL] [Abstract][Full Text] [Related]
14. Cholinergic therapies for Alzheimer's disease: progress and prospects.
Palmer AM
Curr Opin Investig Drugs; 2003 Jul; 4(7):820-5. PubMed ID: 14619403
[TBL] [Abstract][Full Text] [Related]
15. New therapeutic approaches to Alzheimer's disease.
Schneider LS
J Clin Psychiatry; 1996; 57 Suppl 14():30-6. PubMed ID: 9024334
[TBL] [Abstract][Full Text] [Related]
16. The cholinergic hypothesis of cognitive aging revisited again: cholinergic functional compensation.
Dumas JA; Newhouse PA
Pharmacol Biochem Behav; 2011 Aug; 99(2):254-61. PubMed ID: 21382398
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease.
Levy ML; Cummings JL; Kahn-Rose R
Gerontology; 1999; 45 Suppl 1():15-22. PubMed ID: 9876214
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research.
Hampel H; Mesulam MM; Cuello AC; Khachaturian AS; Vergallo A; Farlow MR; Snyder PJ; Giacobini E; Khachaturian ZS
J Prev Alzheimers Dis; 2019; 6(1):2-15. PubMed ID: 30569080
[TBL] [Abstract][Full Text] [Related]
19. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?
Amenta F; Parnetti L; Gallai V; Wallin A
Mech Ageing Dev; 2001 Nov; 122(16):2025-40. PubMed ID: 11589920
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
